Long-Term Effectiveness of XEN 45 Gel-Stent in Open-Angle Glaucoma Patients.

Maria Teresa Marcos-ParraJavier Alejandro Salinas-LópezCarlos Mateos-MarcosLucia Moreno-CastroAngi Lizbeth Mendoza-Moreira Juan José Pérez-Santonja

Published in: Clinical ophthalmology (Auckland, N.Z.) (2023)

XEN implant significantly lowered IOP and reduced the need of ocular hypotensive medication, while maintaining a good safety profile. Beyond week-1, there were no significant differences in IOP lowering between XEN-solo and XEN+Phacoemulsification groups.

Keyphrases

end stage renal disease
ejection fraction
randomized controlled trial
newly diagnosed
systematic review
chronic kidney disease
peritoneal dialysis
clinical trial
emergency department
study protocol